Cory Renauer
Cory Renauer
Stop FollowingCory Renauer
ABOUT
Cory Renauer is a long-term value investor. Although Cory is mainly interested in pharmaceuticals and biotech, he is always on the lookout for well managed companies with predictable earnings growth and significant economic advantages over their competitors.
Cory has a BSc in Biology, and is currently a CFA Candidate. He will sit the Level 1 exam in December 2013.
Cory has a BSc in Biology, and is currently a CFA Candidate. He will sit the Level 1 exam in December 2013.
SNAPSHOT
- Description: Independent / boutique research firm analyst. Trading frequency: Not Trading
- Interests: Stocks - long
COMPANY
Currently, there is no company profile for Cory Renauer.
BLOG
Currently, there are no blog details for Cory Renauer.
Book
Currently, there are no book details for Cory Renauer.
Latest Comments
more »
- If it is Kynamro (mipomerse... on Why Aegerion Is Worth 1,732 Times Sales
- Thank you for the feedback.... on Scrappy Upstarts Aiming For Pfizer's Xalkori Ma...
- Hello Arthurs1,I appreciate... on Why Aegerion Is Worth 1,732 Times Sales
- Thank you,I too believe gro... on Why Aegerion Is Worth 1,732 Times Sales
- You're very welcome. Thanks... on Exelixis And Cabozantinib: ASCO 2013 Highlights
Latest comments on Cory's Articles
- sekingalpha on Sarepta And Eteplirsen: Will 12 Patients Be Eno...
- Carl Cachia on Sarepta And Eteplirsen: Will 12 Patients Be Eno...
- sekingalpha on Sarepta And Eteplirsen: Will 12 Patients Be Eno...
- tredleon on Sarepta And Eteplirsen: Will 12 Patients Be Eno...
- regexpert on Sarepta And Eteplirsen: Will 12 Patients Be Eno...
LATEST ARTICLES & INSTAPOSTS
more »
